Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00935246 |
Recruitment Status : Unknown
Verified December 2015 by Doh Kwan Kim, Samsung Medical Center.
Recruitment status was: Active, not recruiting
First Posted : July 8, 2009
Last Update Posted : December 31, 2015
|
Sponsor:
Samsung Medical Center
Collaborator:
H. Lundbeck A/S
Information provided by (Responsible Party):
Doh Kwan Kim, Samsung Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Actual Primary Completion Date : | October 2011 |
Estimated Study Completion Date : | December 2016 |